ConductScience.org, home

Gene · 5928

RBBP4: RB binding protein 4, chromatin remodeling factor

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. RBBP4: RB binding protein 4, chromatin remodeling factor. Genes, record 5928. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/5928

On this page

Gene

Symbol
RBBP4
HGNC
Name
RB binding protein 4, chromatin remodeling factor
HGNC
NCBI Gene ID
5928
NCBI Gene
HGNC ID
HGNC:9887
HGNC
Ensembl
ENSG00000162521
NCBI Gene
Aliases
NURF55, RBAP48, RbAp48, lin-53
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q09028Histone-binding protein RBBP442553Ensembl, GeneID, HGNC

Source UniProt

Patents63

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
US 12539325 B22026-02-0379Q09028Espacenet
EP 4650780 A22025-11-199323Q09028Espacenet
JP 2025517970 A2025-06-129323Q09028Espacenet
US 12150938 B22024-11-2621Q09028Espacenet
US 12133879 B22024-11-0579Q09028Espacenet
US 11872193 B22024-01-1679Q09028Espacenet
US 11446398 B22022-09-2072855Q09028Espacenet
JP 2022524081 A2022-04-27175826Q09028Espacenet
US 11116755 B22021-09-1421Q09028Espacenet
US 10871495 B22020-12-2216Q09028Espacenet

1 to 10 of 63

See all 63 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants1,692

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleRBBP4 papersNewest fiscal year
P30CA008748Cancer Center Support Grant242025
P30CA016672Cancer Center Support Grant132025
P30CA016087Cancer Center Support Grant122025
R01CA199652Repression via Facultative Heterochromatin92025
P30CA046934University of Colorado Cancer Center Support Grant82025
P30CA060553The Robert H. Lurie Comprehensive Cancer Center62025
R01AG011085Ubiquitin‐mediated proteolysis and cell cycle control62025
R35GM127018Structural studies of function and regulation of microtubules and transcriptional gene expression machinery62025
P40OD010440Caenorhabditis Genetics Center52025
P01CA013106Targeting Transcription and Splicing in Cancer42025

1 to 10 of 1,692Source NIH's project files

See all 1,692 nih grants

Papers2,308

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Distinct NGS mutational landscape and prognostic implications in early-onset colorectal cancer: A dual-cohort analysis of TCGA PanCancer Atlas and MSK-IMPACT 50K.PLoS One202642821536PubTator, text miningPubMed
Tumor-cell PD-L1 expression, mismatch repair status, and survival outcomes in colorectal carcinoma: a retrospective Pakistani cohort study.Front Oncol202642806967PubTator, text miningPubMed
SCRMP-mediated SUMOylation of CSNK2B facilitates DNA damage repair to promote cisplatin resistance in small cell lung cancer.Sci Transl Med202642777084PubTator, text miningPubMed
A Lynch Syndrome Family With Germline MLH1 c.931A>G Showing Preserved Tumor MMR Immunostaining but MSI-H Status: A Case Report.Clin Case Rep202642724513PubTator, text miningPubMed
[Unresectable Gastric Cancer Achieving pCR Via Conversion Surgery after Chemotherapy-Implications for Optimizing Individualized Treatment].Gan To Kagaku Ryoho202642723242PubTator, text miningPubMed
Pathological Complete Response and Conversion Gastrectomy after Nivolumab Plus FOLFOX in an 84-Year-Old Man with MSI-High Gastric Cancer Presenting as a Sister Mary Joseph Nodule: A Case Report.Intern Med202642686572PubTator, text miningPubMed
Multicomplex Integrative Structural Modeling of a Human Histone Deacetylase Interactome.Mol Cell Proteomics202642680104PubTator, text miningPubMed
Multi-Omics-Driven Insights into Cancer Biology and Therapeutic Targeting.AAPS PharmSciTech202642675339PubTator, text miningPubMed
Prevalence of High Tumor Mutational Burden Among Pediatric Patients With Solid Tumors.Pediatr Hematol Oncol202642674063PubTator, text miningPubMed
Integrating perioperative inflammation and pathological invasiveness to predict recurrence after curative colorectal cancer surgery: a multicenter cohort study.Front Oncol202642656393PubTator, text miningPubMed

1 to 10 of 2,308

See all 2,308 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/5928

GET https://conductscience.org/api/genes/v1/5928/patents?page=2